Back to Home
Free On-DemandOn-Demand Panel Discussion

The Clinical Role of Biologics and Steroid-Sparing Strategies in Asthma Care

Release Date

June 24, 2026

Expiration Date

June 25, 2027

Credits

1.5 On-Demand

Topics

Immunology

Program Description

Uncontrolled moderate to severe asthma represents a persistent public health challenge, with substantial economic and quality-of-life burdens for patients. Moderate to severe asthma is characterized by frequent exacerbations and hospitalizations for both adult and pediatric populations. A primary concern in the current landscape is the continued overreliance on systemic corticosteroids, which presents severe cumulative risks including metabolic disorders, bone health issues, and growth suppression. To address these challenges, management strategies are shifting toward the use of precision biologics targeting type 2 inflammation, which offer a crucial steroid-sparing alternative for appropriate patients. This session aims to empower pharmacists to identify patients with uncontrolled asthma and monitor steroid exposure by providing them with the tools to analyze disease burden and interpret biomarkers for accurate patient phenotyping. The discussion will center on strategies pharmacists can implement to navigate reimbursement barriers and lead best practices for biologic integration to become proactive stewards of precision medicine within the multidisciplinary care team.

Target audience: Specialty pharmacists
Type of activity: Application
Release date: June 24, 2026
Expiration date: June 24, 2027
Learner level: Foundational, Intermediate
Time to complete activity: 1.5 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

  • Analyze the burden of uncontrolled asthma and the cumulative physiological risks of systemic corticosteroid (SCS) exposure
  • Identify biomarkers indicating difficult-to-treat and uncontrolled asthma and evidence-based criteria to determine appropriate candidates for biologic therapy
  • Examine the comparative efficacy and safety profiles of biologics targeted to type 2 inflammation in asthma to optimize therapy selection
  • Demonstrate best practices to support the pharmacist’s role on the asthma care team and improve biologic integration
        The Clinical Role of Biologics and Steroid-Sparing Strategies in Asthma Care

        GET STARTED WITH THIS PROGRAM:

        Register now to gain access to this program.

        Create AccountAlready Registered? Login Here

        This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.

        What's Included
        • Access your activities anytime, anywhere, with a computer, tablet or smartphone
        • Free access with a PTCE account
        • Pharmacy education designed to improve patient care

        Follow Us on Social Media!

        Course

        The Clinical Role of Biologics and Steroid-Sparing Strategies in Asthma Care

        Create Account